Stocks Health care NDRA

NASDAQ · Health care

ENDRA Life Sciences Inc. (NDRA)

It posted a net loss of $5.9M. In fiscal 2025 capital spending exceeded operating cash flow by $5.2M. At June 30, 2026 it held $1.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

What ENDRA Life Sciences Inc. does

ENDRA Life Sciences Inc. is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker NDRA.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What ENDRA Life Sciences Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 25, 2026
   Form 425 filing 425
2. September 14, 2026
   Form 425 filing 425
3. August 17, 2026
   Form 425 filing 425
4. August 17, 2026
   Quarterly results 8-K
5. August 14, 2026
   Quarterly report 10-Q · period to June 30, 2026Diluted EPS $0.06 versus -$1.71.
6. July 17, 2026
   Form 425 filing 425
7. July 9, 2026
   Other event 8-K
8. June 29, 2026
   Activist stake changed SCHEDULE 13D/A
9. June 26, 2026
   Form 425 filing 425
10. June 26, 2026
    Change in control 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on June 25, 2026. Insider transactions on SEC

Who owns NDRA

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about NDRA

What does ENDRA Life Sciences Inc. do?

ENDRA Life Sciences Inc. is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker NDRA.

Is ENDRA Life Sciences Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $5.9M.

When did ENDRA Life Sciences Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the form 425 filing from September 25, 2026.

Similar companies

Compare NDRA with

Compare NDRA with any company

Follow NDRA

Get an email when ENDRA Life Sciences Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow NDRA: get an email when it files

Where the numbers come from

Financial figures are the values ENDRA Life Sciences Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.